Traditionally, CRP has been used as a systemic clinical marker of inflammation in COVID-19 and other diseases, although the SROC curves suggest that other acute phase proteins, such as ORM1, CRTAC1, SERPINA3, TF, and AHSG might perform better as biomarkers of inflammation. Here, CRP is linked to COVID-19.